Trial Profile

Single arm, open-label trial to evaluate the safety and efficacy of TP-03 for the treatment of blepharitis due to Demodex infestation

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 May 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lotilaner (Primary)
Indications Blepharitis
Focus Therapeutic Use
Acronyms Mars
Sponsors Tarsus Pharmaceuticals

Most Recent Events

17 May 2021 Status changed from recruiting to completed.
22 Jun 2020 New trial record
15 Jun 2020 According to a Tarsus Pharmaceuticals media release, Dr. Roberto Gonzalez-Salinas, the principal investigator for the study conducted at the Asociacion para Evitar la Ceguera in Mexico City.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com